... caffeine (1 trial).  In 3 trials, sumatriptan treated patients were not significantly more likely to have relief ... points out that health care corporations may regard clinical trials more as marketing tools than as science. We have discussed ... costs and bad outcomes. Also, as we have said before, suppression of results of clinical research that are unfavorable to the vested interests of research ...

... convicted of defrauding his employer of more than $10 million in clinical research funds. Rather than using the money to conduct the trial ... convicted of drug trial fraud can still work in trials in other areas such as medical devices. Another major problem ... corruption. Drug manufacturers are responsible for sponsoring the clinical trials that must be undergone before a new drug can enter the market ...

... the world:  www.ClinicalTrials.gov. Here's how to use this website: Once you have satisfied yourself that you understand what clinical trials are, the risks and benefits of participation, and the questions to ask before you ... help you, the location of the trial or the group sponsoring the trial. Clinical trials.gov is is provided by the US government (National Institutes of Health) and ...

... the following key questions to be answered: How could procedures for multinational trials be effectively streamlined? What changes could improve processes relating to ethics ... differentiating risk operate? How could the participation of non-commercial organisations as sponsors of clinical trials be promoted? Publisher: NHS Confederation Size of Publication: 6p Published: 112/11/2009 Posted in ...

... , Senior Vice President, Data Management, ICON Clinical Research and Claire Castaings, Vice President Worldwide Director, ... , Senior Vice President, Data Management, ICON Clinical Research Claire Castaings, Vice President Worldwide Director, ... event, click here. The integration of data from the various technologies employed in clinical trials continues to increase in complexity. The typical clinical ...

... an agreements with the Food and Drug Administration to re-initiate clinical trials for spinal cord injury. The company said ... spinal cord injury and to support the future expansion of the clinical trial with patients who are suffering from cervical injuries. ... Corporation expects that the data from this study will be able to re-initiate the clinical trial in the third quarter of 2010. Initially, Geron ...